# Nintx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nintx

- Industry: Biotechnology
- Headquarters: Sao Paulo, Brazil
- Website: www.nintx.com.br
- Total disclosed funding: $11M
- Latest round: Series A (Dec 13, 2024)
- Investors on record: 4

## About

Based in Brazil, and founded in 2021 by Miller Freitas, Stephani Saverio, and Cristiano Guimarães Nintx operates as a biotechnology company, that provides novel therapies from complex biological interactions (plants and microorganisms). In August 2022, Nintx raised USD 3 million in seed funding led by The Pitanga Fund, with participation from Marae Investimentos and Individual investors. In December 2024, Nintx raised an undisclosed amount of series A funding led by returning investor Pitanga Invest, with participation from new investors Ecoa Capital and MOV Investimentos. Individuals and other unspecified investors also participated in the round. The round was part of a larger USD 10 million series A and grant funding.

Nintx believes plant-based natural products have potential to serve as a platform for simultaneously modulating human biological targets and the microbiome, thereby providing therapies for multifactorial diseases (multi-target therapies).

## Funding rounds

- Series A, Dec 13, 2024, $8M — Pitanga Invest, MOV Investimentos, Ecoa Capital
- Seed, Aug 4, 2022, $3M — Pitanga Invest, Marae Investimentos

## Investors

- Pitanga Invest (https://capitalatlas.ai/funds/pitanga-invest) — Seed, Series A
- Marae Investimentos — Seed
- MOV Investimentos (https://capitalatlas.ai/funds/mov-investimentos) — Series A
- Ecoa Capital — Series A